DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIALShow others and affiliations
2025 (English)In: Journal of Rheumatology, ISSN 0315-162X, E-ISSN 1499-2752, Vol. 52, no Suppl. 1, p. 11-12, article id O011Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
The Journal of Rheumatology , 2025. Vol. 52, no Suppl. 1, p. 11-12, article id O011
National Category
Rheumatology
Identifiers
URN: urn:nbn:se:oru:diva-125052DOI: 10.3899/jrheum.2025-0390.O011ISI: 001573431600012OAI: oai:DiVA.org:oru-125052DiVA, id: diva2:2014511
Conference
16th International Congress on Systemic Lupus Erythematosus, Toronto, Ontario, Canada, May 21–24, 2025
2025-11-182025-11-182025-11-18Bibliographically approved